The beneficial effect of TZT in T2DM and obesity is related to the direct activation of GIP and GLP-1 receptors with subsequent improvement of insulin sensitivity and reduction of bodyweight. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.